US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Contineum Therapeutics, INC.

13.42

+1.9216.70%

Post-market: 13.19-0.2296-1.71%19:55 EDT

Volume:1.60M

Turnover:20.92M

Market Cap:504.88M

PE:-7.80

High:13.55

Open:11.59

Low:11.59

Close:11.50

52wk High:17.79

52wk Low:8.60

Shares:37.62M

Float Shares:27.82M

Volume Ratio:2.68

T/O Rate:5.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7201

EPS(LYR):-2.1700

ROE:-28.01%

ROA:-19.15%

PB:2.11

PE(LYR):-6.18

Loading ...

Overview Company News Filings

Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint

Contineum Therapeutics Reports Phase 2 MOONLIGHT-1 Results

Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal

Contineum says MOONLIGHT-1 trial did not achieve its primary endpoint

Contineum down 11% atter MOONLIGHT-1 trial did not achieve endpoint

Contineum Therapeutics, - Jnj-5120/Pipe-307 Well-Tolerated with no New Safety Signals

THOMSON REUTERS

Contineum Therapeutics, - Analyses of Data Including Exploratory Endpoints are Ongoing

THOMSON REUTERS

Contineum Therapeutics Reports Phase 2 Results for Jnj-5120/Pipe-307 for the Treatment of Major Depressive Disorder

THOMSON REUTERS

Contineum Therapeutics, - Phase 2 Moonlight-1 Trial Did not Meet Primary Efficacy Endpoint

THOMSON REUTERS

Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307

THOMSON REUTERS

Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Common Shares for $41,141.5

Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from RBC Capital

Contineum Therapeutics to Present at Morgan Stanley Global Healthcare Conference

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

MT Newswires Live

Contineum Therapeutics, Inc. Class A (CTNM) Gets a Hold from Morgan Stanley

Morgan Stanley Adjusts PT on Contineum Therapeutics to $18 From $16, Keeps Equalweight Rating

MT Newswires Live

Contineum Therapeutics CEO Carmine Stengone Disposes of Shares Worth $40,029

Contineum Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Buy Rating Reaffirmed on Contineum Therapeutics with Unchanged $26 Price Target, Backed by Advancing IPF and MDD Pipelines

Contineum Therapeutics is Maintained at Outperform by RBC Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/CTNM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":13.42,"timestamp":1790798400000,"preClose":11.5,"halted":0,"volume":1597799,"hourTrading":{"tag":"盘后","latestPrice":13.1904,"preClose":13.42,"latestTime":"19:55 EDT","volume":1072,"amount":14308.8122,"timestamp":1790812502672,"change":-0.2296,"changeRate":-0.017109,"amplitude":0.017109},"delay":0,"changeRate":0.16695652173913042,"floatShares":27823300,"shares":37621100,"eps":-1.720127,"marketStatus":"Not Yet Opened","change":1.92,"latestTime":"09-30 16:00:00 EDT","open":11.59,"high":13.545,"low":11.59,"amount":20920389.745745,"amplitude":0.17,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.720127,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":11.5,"preHourTrading":{"tag":"盘前","latestPrice":12.01,"preClose":11.5,"latestTime":"09:24 EDT","volume":3168,"amount":36743.70744,"timestamp":1790774682679,"change":0.51,"changeRate":0.044348,"amplitude":0.082609},"postHourTrading":{"tag":"盘后","latestPrice":13.1904,"preClose":13.42,"latestTime":"19:55 EDT","volume":1072,"amount":14308.8122,"timestamp":1790812502672,"change":-0.2296,"changeRate":-0.017109,"amplitude":0.017109},"volumeRatio":2.682903,"impliedVol":1.9913,"impliedVolPercentile":0.8964},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","floatShares":27823300,"roa":"-19.15%","roe":"-28.01%","lyrEps":-2.169999,"volumeRatio":2.682903,"shares":37621100,"dividePrice":0,"high":13.545,"amplitude":0.17,"preClose":11.5,"low":11.59,"week52Low":8.6,"pbRate":"2.11","week52High":17.785,"institutionHeld":0,"latestPrice":13.42,"eps":-1.720127,"divideRate":0,"volume":1597799,"delay":0,"ttmEps":-1.720127,"open":11.59,"prevYearClose":11.43,"prevWeekClose":12.56,"prevMonthClose":16.24,"prevQuarterClose":16.39,"fiveDayClose":12.51,"twentyDayClose":16.55,"sixtyDayClose":14.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"CTNM","fiscalQuarterEnding":"2026/06","expectedEps":-0.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2026-05-05","symbol":"CTNM","fiscalQuarterEnding":"2026/03","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2026-03-05","symbol":"CTNM","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-10-30","symbol":"CTNM","fiscalQuarterEnding":"2025/09","expectedEps":-0.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-08-05","symbol":"CTNM","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1785556800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTNM","date":"2026-09-29","current":-7.80175,"percent":0.374793,"low":-16.425726,"twenty":-9.925272,"median":-6.169394,"eighty":-2.437893,"high":28.322904,"avg":-4.20322,"sd":9.875799,"marketCap":478917010},"quantilePoints":[{"date":"2024-04-05","current":16.281367,"twenty":16.281367,"median":16.281367,"eighty":16.281367,"marketCap":369912656},{"date":"2024-04-12","current":17.609251,"twenty":16.281367,"median":16.569509,"eighty":16.868158,"marketCap":400082176},{"date":"2024-04-19","current":17.122563,"twenty":16.281367,"median":16.868158,"eighty":17.144685,"marketCap":389024629},{"date":"2024-04-26","current":17.686678,"twenty":16.315104,"median":17.089379,"eighty":17.59819,"marketCap":401841332},{"date":"2024-05-03","current":16.48102,"twenty":16.48102,"median":17.122563,"eighty":17.59819,"marketCap":374448771},{"date":"2024-05-10","current":17.719862,"twenty":16.38147,"median":17.105971,"eighty":17.59819,"marketCap":402595255},{"date":"2024-05-17","current":16.547386,"twenty":16.392531,"median":17.100441,"eighty":17.487579,"marketCap":375956618},{"date":"2024-05-24","current":17.819411,"twenty":16.48102,"median":17.133624,"eighty":17.59819,"marketCap":404857026},{"date":"2024-05-31","current":20.173009,"twenty":16.534113,"median":17.172337,"eighty":17.68889,"marketCap":385849140},{"date":"2024-06-07","current":21.67926,"twenty":16.768608,"median":17.354846,"eighty":18.209439,"marketCap":414659209},{"date":"2024-06-14","current":22.311348,"twenty":16.85046,"median":17.388029,"eighty":20.619504,"marketCap":426749148},{"date":"2024-06-21","current":26.466988,"twenty":16.894704,"median":17.487579,"eighty":21.17897,"marketCap":506234071},{"date":"2024-06-28","current":25.216261,"twenty":16.921251,"median":17.542884,"eighty":21.517876,"marketCap":482311425},{"date":"2024-07-05","current":27.018383,"twenty":16.987617,"median":17.609251,"eighty":21.78147,"marketCap":516780614},{"date":"2024-07-12","current":28.242212,"twenty":17.042923,"median":17.692208,"eighty":22.916538,"marketCap":540188796},{"date":"2024-07-15","current":27.932893,"twenty":17.049559,"median":17.697739,"eighty":23.766494,"marketCap":534272442},{"date":"2024-08-02","current":26.224911,"twenty":17.056196,"median":17.697739,"eighty":24.100021,"marketCap":501603882},{"date":"2024-08-09","current":22.338245,"twenty":17.08938,"median":17.819411,"eighty":24.409341,"marketCap":427263614},{"date":"2024-08-16","current":-15.206885,"twenty":17.023013,"median":17.769636,"eighty":24.100021,"marketCap":478195700},{"date":"2024-08-23","current":-14.92058,"twenty":16.547386,"median":17.697739,"eighty":23.683112,"marketCap":469192554},{"date":"2024-08-30","current":-15.468649,"twenty":16.315104,"median":17.614781,"eighty":23.293101,"marketCap":486427149},{"date":"2024-09-06","current":-14.511573,"twenty":15.417858,"median":17.570537,"eighty":22.830467,"marketCap":456330916},{"date":"2024-09-13","current":-14.765157,"twenty":-14.025672,"median":17.410151,"eighty":22.682531,"marketCap":464305131},{"date":"2024-09-20","current":-16.425726,"twenty":-14.408503,"median":17.365907,"eighty":22.459283,"marketCap":516523382},{"date":"2024-09-27","current":-15.272326,"twenty":-14.745525,"median":17.19999,"eighty":22.405488,"marketCap":480253562},{"date":"2024-10-04","current":-14.421591,"twenty":-14.887859,"median":17.133624,"eighty":22.351694,"marketCap":453501355},{"date":"2024-10-11","current":-13.521775,"twenty":-14.788061,"median":17.100441,"eighty":22.316727,"marketCap":425205752},{"date":"2024-10-18","current":-13.480875,"twenty":-14.745525,"median":17.039604,"eighty":22.010098,"marketCap":423919588},{"date":"2024-10-25","current":-13.309092,"twenty":-14.662087,"median":16.868158,"eighty":21.934785,"marketCap":418517700},{"date":"2024-10-31","current":-14.004404,"twenty":-14.595828,"median":16.547386,"eighty":21.78147,"marketCap":440382485},{"date":"2024-11-08","current":-13.455721,"twenty":-14.532841,"median":16.387,"eighty":21.655052,"marketCap":477166769},{"date":"2024-11-15","current":-13.193473,"twenty":-14.477216,"median":16.281367,"eighty":21.566291,"marketCap":467866942},{"date":"2024-11-22","current":-10.423934,"twenty":-14.434679,"median":15.167037,"eighty":21.517876,"marketCap":369653551},{"date":"2024-11-29","current":-10.838275,"twenty":-14.411775,"median":-9.795154,"eighty":21.388769,"marketCap":384346893},{"date":"2024-12-06","current":-10.358512,"twenty":-14.347406,"median":-10.271282,"eighty":21.17897,"marketCap":367333550},{"date":"2024-12-13","current":-10.031401,"twenty":-14.270231,"median":-10.358512,"eighty":21.154762,"marketCap":355733543},{"date":"2024-12-20","current":-9.70429,"twenty":-14.217087,"median":-10.242206,"eighty":20.950342,"marketCap":344133536},{"date":"2024-12-27","current":-10.569317,"twenty":-14.14183,"median":-10.271282,"eighty":20.635643,"marketCap":374809110},{"date":"2025-01-03","current":-10.525702,"twenty":-14.135286,"median":-10.358512,"eighty":20.603366,"marketCap":373262442},{"date":"2025-01-10","current":-9.718828,"twenty":-14.073857,"median":-10.358512,"eighty":20.25908,"marketCap":344649092},{"date":"2025-01-17","current":-9.071876,"twenty":-14.047944,"median":-10.256744,"eighty":19.850241,"marketCap":321706856},{"date":"2025-01-24","current":-8.19958,"twenty":-14.045305,"median":-10.209494,"eighty":18.599466,"marketCap":290773505},{"date":"2025-01-31","current":-7.429052,"twenty":-14.035488,"median":-10.009594,"eighty":17.759682,"marketCap":263449044},{"date":"2025-02-07","current":-6.883867,"twenty":-14.024036,"median":-9.925999,"eighty":17.706588,"marketCap":244115699},{"date":"2025-02-14","current":-5.589962,"twenty":-14.010948,"median":-9.718828,"eighty":17.697739,"marketCap":198231228},{"date":"2025-02-21","current":-5.742614,"twenty":-13.988044,"median":-9.667944,"eighty":17.693315,"marketCap":203644564},{"date":"2025-02-28","current":-5.19016,"twenty":-13.940599,"median":-9.518928,"eighty":17.660132,"marketCap":184053442},{"date":"2025-03-07","current":-3.942751,"twenty":-13.847345,"median":-9.071876,"eighty":17.615888,"marketCap":166612775},{"date":"2025-03-14","current":-4.371311,"twenty":-13.716463,"median":-8.19958,"eighty":17.604827,"marketCap":184722859},{"date":"2025-03-21","current":-4.377433,"twenty":-13.63957,"median":-8.126889,"eighty":17.576068,"marketCap":184981575},{"date":"2025-03-28","current":-4.561102,"twenty":-13.619937,"median":-7.567165,"eighty":17.520762,"marketCap":192743040},{"date":"2025-04-04","current":-3.75296,"twenty":-13.617995,"median":-7.116479,"eighty":17.456608,"marketCap":158592595},{"date":"2025-04-11","current":-2.528503,"twenty":-13.600664,"median":-6.847522,"eighty":17.401302,"marketCap":106849497},{"date":"2025-04-17","current":-2.681561,"twenty":-13.574128,"median":-6.436815,"eighty":17.385817,"marketCap":113317384},{"date":"2025-04-25","current":-2.767272,"twenty":-13.55286,"median":-5.742614,"eighty":17.372544,"marketCap":116939401},{"date":"2025-05-02","current":-2.430547,"twenty":-13.541408,"median":-5.640845,"eighty":17.334936,"marketCap":102710049},{"date":"2025-05-09","current":-2.418302,"twenty":-13.513595,"median":-5.553616,"eighty":17.244235,"marketCap":102192618},{"date":"2025-05-16","current":-2.045592,"twenty":-13.477603,"median":-5.430041,"eighty":17.188929,"marketCap":101933903},{"date":"2025-05-23","current":-2.030017,"twenty":-13.462755,"median":-5.321004,"eighty":17.144685,"marketCap":101157756},{"date":"2025-05-30","current":-1.853493,"twenty":-13.455721,"median":-5.117468,"eighty":17.144685,"marketCap":92361429},{"date":"2025-06-06","current":-2.154621,"twenty":-13.448154,"median":-4.770625,"eighty":17.122563,"marketCap":107366928},{"date":"2025-06-13","current":-2.40383,"twenty":-13.399073,"median":-4.628447,"eighty":17.122563,"marketCap":119785271},{"date":"2025-06-20","current":-1.895028,"twenty":-13.379975,"median":-4.585591,"eighty":17.104865,"marketCap":94431153},{"date":"2025-06-27","current":-2.081935,"twenty":-13.328858,"median":-4.536848,"eighty":17.091592,"marketCap":103744911},{"date":"2025-07-03","current":-2.014441,"twenty":-13.312364,"median":-4.445597,"eighty":17.06947,"marketCap":100381610},{"date":"2025-07-11","current":-2.092319,"twenty":-13.309092,"median":-4.377433,"eighty":17.036286,"marketCap":104262342},{"date":"2025-07-18","current":-1.993674,"twenty":-13.304184,"median":-4.325394,"eighty":16.96992,"marketCap":99346748},{"date":"2025-07-25","current":-2.959359,"twenty":-13.281279,"median":-4.150909,"eighty":16.894704,"marketCap":147467829},{"date":"2025-08-01","current":-3.063196,"twenty":-13.22336,"median":-4.01928,"eighty":16.841612,"marketCap":152642139},{"date":"2025-08-08","current":-3.062072,"twenty":-13.164683,"median":-3.75296,"eighty":16.657997,"marketCap":174115524},{"date":"2025-08-15","current":-3.58032,"twenty":-12.764301,"median":-3.489183,"eighty":16.507566,"marketCap":203584157},{"date":"2025-08-22","current":-4.951297,"twenty":-12.507357,"median":-3.639499,"eighty":16.427927,"marketCap":281540625},{"date":"2025-08-29","current":-4.956228,"twenty":-11.906412,"median":-3.948873,"eighty":16.385894,"marketCap":281821044},{"date":"2025-09-05","current":-5.419796,"twenty":-11.370375,"median":-4.039068,"eighty":16.354924,"marketCap":308180426},{"date":"2025-09-12","current":-5.824184,"twenty":-11.101417,"median":-4.150909,"eighty":16.301609,"marketCap":331174779},{"date":"2025-09-19","current":-6.115147,"twenty":-10.938589,"median":-4.325394,"eighty":16.232919,"marketCap":347719498},{"date":"2025-09-26","current":-5.355685,"twenty":-10.838275,"median":-4.374303,"eighty":15.930178,"marketCap":304534979},{"date":"2025-10-03","current":-5.301438,"twenty":-10.774307,"median":-4.411924,"eighty":15.250644,"marketCap":301450371},{"date":"2025-10-10","current":-5.996789,"twenty":-10.666723,"median":-4.53049,"eighty":8.143309,"marketCap":340989443},{"date":"2025-10-17","current":-6.144737,"twenty":-10.617293,"median":-4.573346,"eighty":-1.787038,"marketCap":349402011},{"date":"2025-10-24","current":-5.483906,"twenty":-10.566409,"median":-4.58636,"eighty":-1.820784,"marketCap":311825872},{"date":"2025-10-31","current":-5.197875,"twenty":-10.55914,"median":-4.692731,"eighty":-1.833764,"marketCap":295561573},{"date":"2025-11-07","current":-5.410266,"twenty":-10.548963,"median":-4.832939,"eighty":-1.851935,"marketCap":321299446},{"date":"2025-11-14","current":-5.356212,"twenty":-10.534425,"median":-4.919242,"eighty":-1.870107,"marketCap":318089369},{"date":"2025-11-21","current":-6.004854,"twenty":-10.522794,"median":-4.956228,"eighty":-1.897105,"marketCap":356610284},{"date":"2025-11-28","current":-5.439749,"twenty":-10.511164,"median":-5.1056,"eighty":-1.907489,"marketCap":323050396},{"date":"2025-12-05","current":-5.395524,"twenty":-10.480633,"median":-5.127036,"eighty":-1.940717,"marketCap":320423970},{"date":"2025-12-12","current":-6.422541,"twenty":-10.474818,"median":-5.15474,"eighty":-1.961484,"marketCap":381415418},{"date":"2025-12-19","current":-5.596996,"twenty":-10.473364,"median":-5.194017,"eighty":-1.980175,"marketCap":332388800},{"date":"2025-12-26","current":-6.230896,"twenty":-10.467549,"median":-5.225482,"eighty":-1.988482,"marketCap":370034239},{"date":"2026-01-02","current":-5.616652,"twenty":-10.432657,"median":-5.250562,"eighty":-1.988482,"marketCap":333556100},{"date":"2026-01-09","current":-5.640545,"twenty":-10.418119,"median":-5.238277,"eighty":-1.992636,"marketCap":334975047},{"date":"2026-01-16","current":-7.282885,"twenty":-10.370143,"median":-5.311221,"eighty":-1.993674,"marketCap":432508676},{"date":"2026-01-23","current":-7.76882,"twenty":-10.358512,"median":-5.340862,"eighty":-1.996789,"marketCap":461366940},{"date":"2026-01-30","current":-8.980584,"twenty":-10.345428,"median":-5.356212,"eighty":-2.000423,"marketCap":533329955},{"date":"2026-02-06","current":-8.906771,"twenty":-10.297451,"median":-5.376869,"eighty":-2.009249,"marketCap":528946421},{"date":"2026-02-13","current":-9.152815,"twenty":-10.253836,"median":-5.386426,"eighty":-2.014441,"marketCap":543558201},{"date":"2026-02-20","current":-9.841736,"twenty":-10.233483,"median":-5.400438,"eighty":-2.020671,"marketCap":584471184},{"date":"2026-02-27","current":-9.706412,"twenty":-10.211675,"median":-5.415031,"eighty":-2.032093,"marketCap":576434705},{"date":"2026-03-06","current":-8.494648,"twenty":-10.131715,"median":-5.429659,"eighty":-2.035208,"marketCap":504471690},{"date":"2026-03-13","current":-8.627788,"twenty":-10.022678,"median":-5.439635,"eighty":-2.037285,"marketCap":517477458},{"date":"2026-03-20","current":-7.538421,"twenty":-10.003778,"median":-5.449385,"eighty":-2.042477,"marketCap":452139395},{"date":"2026-03-27","current":-8.497064,"twenty":-9.968886,"median":-5.459248,"eighty":-2.051822,"marketCap":509636891},{"date":"2026-04-02","current":-8.372565,"twenty":-9.928179,"median":-5.466715,"eighty":-2.065321,"marketCap":502169684},{"date":"2026-04-10","current":-7.986617,"twenty":-9.906238,"median":-5.479061,"eighty":-2.081935,"marketCap":479021341},{"date":"2026-04-17","current":-8.27919,"twenty":-9.836054,"median":-5.512918,"eighty":-2.084012,"marketCap":496569278},{"date":"2026-04-24","current":-7.731394,"twenty":-9.810397,"median":-5.553616,"eighty":-2.100626,"marketCap":463713567},{"date":"2026-05-01","current":-7.980392,"twenty":-9.782709,"median":-5.593479,"eighty":-2.134892,"marketCap":478647981},{"date":"2026-05-08","current":-9.346147,"twenty":-9.716345,"median":-5.597332,"eighty":-2.142161,"marketCap":546226206},{"date":"2026-05-15","current":-9.090076,"twenty":-9.706412,"median":-5.616855,"eighty":-2.169158,"marketCap":531260417},{"date":"2026-05-22","current":-9.192428,"twenty":-9.705988,"median":-5.636308,"eighty":-2.233537,"marketCap":537242237},{"date":"2026-05-29","current":-8.51435,"twenty":-9.70429,"median":-5.640545,"eighty":-2.258458,"marketCap":497612677},{"date":"2026-06-05","current":-7.893845,"twenty":-9.687959,"median":-5.659308,"eighty":-2.268842,"marketCap":461347892},{"date":"2026-06-12","current":-7.586791,"twenty":-9.667944,"median":-5.675619,"eighty":-2.28961,"marketCap":443402431},{"date":"2026-06-18","current":-7.7787,"twenty":-9.662129,"median":-5.714931,"eighty":-2.297916,"marketCap":454618344},{"date":"2026-06-26","current":-8.546335,"twenty":-9.628373,"median":-5.735345,"eighty":-2.299993,"marketCap":499481996},{"date":"2026-07-02","current":-9.748963,"twenty":-9.663583,"median":-5.762064,"eighty":-2.315568,"marketCap":569768385},{"date":"2026-07-10","current":-9.883299,"twenty":-9.694491,"median":-5.794595,"eighty":-2.329935,"marketCap":577619524},{"date":"2026-07-17","current":-8.962137,"twenty":-9.694491,"median":-5.82665,"eighty":-2.336264,"marketCap":523783141},{"date":"2026-07-24","current":-9.192428,"twenty":-9.67595,"median":-5.858705,"eighty":-2.342386,"marketCap":537242237},{"date":"2026-07-31","current":-10.230297,"twenty":-9.679953,"median":-5.883363,"eighty":-2.347666,"marketCap":588835437},{"date":"2026-08-07","current":-10.033086,"twenty":-9.712752,"median":-5.989392,"eighty":-2.358877,"marketCap":577484376},{"date":"2026-08-14","current":-10.000405,"twenty":-9.736909,"median":-5.997033,"eighty":-2.370666,"marketCap":575603319},{"date":"2026-08-21","current":-10.471012,"twenty":-9.774333,"median":-6.022053,"eighty":-2.376833,"marketCap":602690534},{"date":"2026-08-28","current":-11.274967,"twenty":-9.837227,"median":-6.092955,"eighty":-2.39137,"marketCap":648964527},{"date":"2026-09-04","current":-11.484125,"twenty":-9.932538,"median":-6.109132,"eighty":-2.409619,"marketCap":661003289},{"date":"2026-09-11","current":-9.582088,"twenty":-9.971533,"median":-6.111778,"eighty":-2.420751,"marketCap":551525795},{"date":"2026-09-18","current":-8.634337,"twenty":-9.933507,"median":-6.142445,"eighty":-2.430547,"marketCap":496975153},{"date":"2026-09-25","current":-8.163729,"twenty":-9.928179,"median":-6.158368,"eighty":-2.432996,"marketCap":469887938},{"date":"2026-09-29","current":-8.320599,"twenty":-9.925272,"median":-6.169394,"eighty":-2.437893,"marketCap":478917010}],"updateTime":1790827613618},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTNM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667695187","title":"Contineum Therapeutics Shares Fall After Drug Trial Missed Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695187","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695187?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"Shares of Contineum Therapeutics were trading lower after-hours Monday, following news a Phase 2 trial of an treatment for depression failed to meet its primary efficacy endpoint.Contineum said JNJ-5120/PIPE-307 is being developed by Johnson & Johnson under a global license and development agreement. The Phase 2 Moonlight-1 trial didn't meet its primary efficacy endpoint, although the treatment was well-tolerated with no new safety signals, the company added.Analyses of the data are ongoing, Contineum said.After the bell, shares of Contineum were trading 8.2% lower, at $13.59.  The stock ended the day's regular session flat, at $14.82.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU0345769128.USD","IE00B19Z3B42.SGD","GDOC","IE00BFTCPJ56.SGD","SG9999001176.USD","VHT","LU0943347566.SGD","IE000BZT7R73.USD","LU2456880835.USD","IE00BLSP4452.SGD","LU0792757196.USD","LU0210528500.USD","BK4550","FTXH","LU1551013342.USD","LU2430703251.USD","PJP","RXL","IXJ","CTNM","JNJ","LU0162691827.USD","LU0426417589.USD","LU1674673691.USD","IE0009355771.USD","IE0002141913.USD","LU2430703178.SGD","SGXZ80539844.SGD","LU0124676726.USD","IYH","LU0994945656.USD","BK4559","LU0114720955.EUR","LU1228905540.USD","LU0203345920.USD","LU0820562030.AUD","MEDX","LU0057025933.USD","LU2213496289.HKD","BMED","LU0345770308.USD","IE00BGHQF631.EUR","IE00BN8TJ469.HKD","IHE","JDOC","XLV","TRUH","LU1162221912.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667954476","title":"Contineum Therapeutics Reports Phase 2 MOONLIGHT-1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667954476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667954476?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:31","pubTimestamp":1789417870,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Contineum Therapeutics, Inc. Class A ( ($CTNM) ). On September 14, 2026, Contineum Therapeutics reported top-li...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-reports-phase-2-moonlight-1-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-therapeutics-reports-phase-2-moonlight-1-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667769302","title":"Contineum, J&J's Depression Drug Fails to Meet Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2667769302","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667769302?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:11","pubTimestamp":1789416676,"startTime":"0","endTime":"0","summary":"Contineum, J&J's depression drug fails to meet mid-stage trial goalSept 15 (Reuters)-Contineum TherapeuticsCTNM.Osaid on Monday an experimental depression drug it developed with Johnson & JohnsonJNJ.Nfailed to meet the main goal of a mid-stage study.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4561IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","RXL","BK4559","VHT","IE00B3T34201.USD","IE000M9KFDE8.USD","LU0912757837.SGD","LU1121112475.USD","IE00B19Z3581.USD","LU2487616109.SGD","IXJ","IE00BN8TJ469.HKD","TRUH","IE00BZ1G4Q59.USD","LU1074936037.SGD","MEDX","LU1196500208.SGD","IE00BVYPNV92.GBP","IYH","IE000WAW04H5.SGD","FHLC","LU2236285917.USD","IE00B3PB1722.GBP","CTNM","LU1043141123.HKD","IE0009355771.USD","LU2129689605.HKD","LU0820561818.USD","IE00BDGV0183.EUR","LU1674673428.USD","IHE","GDOC","FTXH","XLV","LU0345769631.USD","LU1430594728.SGD","LU2505996509.AUD","LU2023250330.USD","LU1629891620.HKD","BMED","LU0234572021.USD","JNJ","LU1894683348.USD","LU1929549753.HKD","JDOC","SGXZ57979304.SGD","LU2592432038.USD","LU1894683264.USD","LU2133065610.SGD","LU2213496289.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667469539","title":"Contineum says MOONLIGHT-1 trial did not achieve its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2667469539","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667469539?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:10","pubTimestamp":1789416618,"startTime":"0","endTime":"0","summary":"The company states: “Contineum (CTNM) Therapeutics announced that the MOONLIGHT-1 trial did not achieve its primary efficacy endpoint. The trial ev...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-says-moonlight-1-trial-did-not-achieve-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-says-moonlight-1-trial-did-not-achieve-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695366","title":"Contineum down 11% atter MOONLIGHT-1 trial did not achieve endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695366","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695366?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:10","pubTimestamp":1789416607,"startTime":"0","endTime":"0","summary":"16:09 EDT Contineum (CTNM) down 11% atter MOONLIGHT-1 trial did not achieve endpoint Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-down-11-atter-moonlight-1-trial-did-not-achieve-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-down-11-atter-moonlight-1-trial-did-not-achieve-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667937696","title":"Contineum Therapeutics, - Jnj-5120/Pipe-307 Well-Tolerated with no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2667937696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667937696?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABTMJR3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667752693","title":"Contineum Therapeutics, - Analyses of Data Including Exploratory Endpoints are Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667752693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667752693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABTMJR3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693793","title":"Contineum Therapeutics Reports Phase 2 Results for Jnj-5120/Pipe-307 for the Treatment of Major Depressive Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693793?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABTMJR3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693759","title":"Contineum Therapeutics, - Phase 2 Moonlight-1 Trial Did not Meet Primary Efficacy Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693759?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABTMJR3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693701","title":"Contineum Therapeutics, - Johnson & Johnson Continues to Evaluate Trial Data for Jnj-5120/Pipe-307","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693701?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABTMJR3:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","LU0820562030.AUD","VHT","BMED","IYH","JDOC","JNJ","LU1935042991.SGD","FHLC","IE0001KFT4U8.USD","LU1929549753.HKD","TRUH","LU0289961442.SGD","IXJ","LU1043141123.HKD","LU0098860793.USD","GDOC","PJP","LU0882574055.USD","LU0345770993.USD","IE00BGHQF631.EUR","LU1674673428.USD","LU0345769128.USD","LU1989771016.USD","LU0210536198.USD","RXL","BK4533","LU0545562505.USD","FTXH","LU0432979614.USD","LU1066051498.USD","LU2456880835.USD","IE0002141913.USD","LU2468319806.SGD","LU0994945656.USD","XLV","LU0792757196.USD","LU0203347892.USD","LU0072461881.USD","LU0053666078.USD","LU1496350502.SGD","IE00B42XCP33.USD","IHE","LU1043141396.HKD","LU1674673691.USD","CTNM","SG9999001440.SGD","LU1145028129.USD","IE000BZT7R73.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370027","title":"Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Common Shares for $41,141.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370027","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370027?lang=en_us&edition=fundamental","pubTime":"2026-09-09 06:09","pubTimestamp":1788905361,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CEO Carmine N. Stengone disposes of 2,500 common shares for $41,141.5Contineum Therapeutics CEO and President Carmine N. Stengone sold 2,500 Class A common shares at USD 16.46 o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9hqqxt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CEO Carmine N. Stengone Disposes of 2,500 Common Shares for $41,141.5","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587900","title":"Contineum Therapeutics, Inc. Class A (CTNM) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587900?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:35","pubTimestamp":1788435326,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Buy rating on Contineum Therapeutics, Inc. Class A today and set a price target of $23.00. Accordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/contineum-therapeutics-inc-class-a-ctnm-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/contineum-therapeutics-inc-class-a-ctnm-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","LU0310800379.SGD","LU1267930573.SGD","BK4007","LU0708994859.HKD","BK4207","LU0128525929.USD","GSIB","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731791","title":"Contineum Therapeutics to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731791?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:29","pubTimestamp":1787736547,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics to present at Morgan Stanley Global Healthcare ConferenceContineum will present at the 2026 Morgan Stanley Global Healthcare Conference on Sept. 15.Management is scheduled for a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8WJ3Xp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660435025","title":"Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435025?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:01","pubTimestamp":1786978897,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics , Disc Medicine , and Recursion Pharmaceuticals  are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.Contineum had a solid Q2, with the company advancing PIPE-791 toward a potentially large idiopathic pulmonary fibrosis opportunity, backed by strong trial progress, better tolerability, additional chronic-pain potential, and enough cash to fund operations through mid-2029, the investment firm said.Morgan Stanley said Disc Medicine is seeing \"very strong\" demand for bitopertin, with its expanded access program launched ahead of a phase 3 trial readout expected in Q4. Management says demand is currently limited by operational bandwidth, not patient interest, according to the note.Recursion Pharmaceuticals is showing growing validation of its artificial intelligence drug-discovery platform, the firm said. The company cut its 2026 cash spending forecast to about $375 million from rough","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4139","BK4007","CTNM","BK4539","IRON","RXRX","BK4609","LU0053671581.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480080","title":"Contineum Therapeutics, Inc. Class A (CTNM) Gets a Hold from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480080","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480080?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:58","pubTimestamp":1786971504,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Contineum Therapeutics, Inc. Class A, with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/contineum-therapeutics-inc-class-a-ctnm-gets-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/contineum-therapeutics-inc-class-a-ctnm-gets-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489350","title":"Morgan Stanley Adjusts PT on Contineum Therapeutics to $18 From $16, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489350","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489350?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:54","pubTimestamp":1786960464,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics (CTNM) has an average rating of buy and mean price target of $23.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656130033","title":"Contineum Therapeutics CEO Carmine Stengone Disposes of Shares Worth $40,029","url":"https://stock-news.laohu8.com/highlight/detail?id=2656130033","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656130033?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:15","pubTimestamp":1785795310,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics CEO Carmine Stengone disposes of shares worth $40,029Contineum Therapeutics CEO and President Carmine N. Stengone sold 2,500 Class A common shares at USD 16.01 on Aug. 3, 2026.H","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLVFjCh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CEO Carmine Stengone Disposes of Shares Worth $40,029","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656937662","title":"Contineum Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656937662","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656937662?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:00","pubTimestamp":1785758435,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryContineum Therapeutics IncCTNM.OQreported a quarterly adjusted loss of 40 cents per share for the quarter end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N440145:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395734","title":"Buy Rating Reaffirmed on Contineum Therapeutics with Unchanged $26 Price Target, Backed by Advancing IPF and MDD Pipelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395734","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395734?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:55","pubTimestamp":1785524128,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on CTNM stock, giving a Buy rating today. Debanjana Chatterjee has gi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-contineum-therapeutics-with-unchanged-26-price-target-backed-by-advancing-ipf-and-mdd-pipelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reaffirmed-on-contineum-therapeutics-with-unchanged-26-price-target-backed-by-advancing-ipf-and-mdd-pipelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395408","title":"Contineum Therapeutics is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395408?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:53","pubTimestamp":1785523980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTNM/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":74,"code":"91000000","status":"200"}]}}